Avanos Medical FY2026 EPS Estimate Lowered by Zacks Research

Avanos Medical, Inc. (NYSE:AVNS) – Equities research analysts at Zacks Research reduced their FY2026 earnings per share estimates for Avanos Medical in a report issued on Tuesday, December 31st. Zacks Research analyst R. Department now anticipates that the company will post earnings of $1.99 per share for the year, down from their prior estimate of $2.00. The consensus estimate for Avanos Medical’s current full-year earnings is $1.32 per share.

Separately, StockNews.com downgraded shares of Avanos Medical from a “strong-buy” rating to a “buy” rating in a report on Sunday, November 3rd.

Avanos Medical Trading Down 0.6 %

Shares of AVNS stock opened at $15.83 on Friday. Avanos Medical has a 1-year low of $15.51 and a 1-year high of $25.36. The firm’s 50-day simple moving average is $18.46 and its 200-day simple moving average is $21.06. The firm has a market cap of $727.50 million, a P/E ratio of 46.56 and a beta of 0.95. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.22 and a quick ratio of 1.46.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of AVNS. Quarry LP bought a new stake in shares of Avanos Medical in the third quarter worth about $42,000. KBC Group NV boosted its holdings in shares of Avanos Medical by 63.0% during the 3rd quarter. KBC Group NV now owns 2,833 shares of the company’s stock worth $68,000 after buying an additional 1,095 shares during the period. Canada Pension Plan Investment Board acquired a new stake in shares of Avanos Medical during the second quarter worth $70,000. XTX Topco Ltd acquired a new position in Avanos Medical in the 2nd quarter valued at $202,000. Finally, Intech Investment Management LLC bought a new position in Avanos Medical in the third quarter valued at approximately $207,000. Institutional investors own 95.17% of the company’s stock.

About Avanos Medical

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.